<DOC>
	<DOCNO>NCT01746628</DOCNO>
	<brief_summary>When certain type outpatient surgery inside uterine cavity woman experience heavy bleeding . The method presently available control bleeding , short remove uterus , involve placement balloon pressure device inside uterine cavity . The pressure along patient 's natural clotting ability generally stop bleeding . However , treatment usually require least 24 hour stay hospital . The investigator research use compound ( FloSeal ) already approve use area human body , method control bleeding . The use FloSeal uterine cavity yet test therefore yet FDA approve indication safe use control bleed uterine cavity . In study , The investigator want find effect ( ) FloSeal uterine cavity . Twenty individual include study Northwest Hospital Center . All twenty individual treat fashion except ten participant randomly assign receive FloSeal ten . Study participant individual currently schedule hysterectomy procedure , involve surgically remove uterus body previously determine standard care treatment non- cancerous medical problem . Before perform hysterectomy evaluate effect FloSeal upon tissue within uterine cavity follow do . Once anesthesia uterine cavity subject curettage ( sharp scrapping ) produce minor amount bleed line uterus . Ten 20 study participant , randomly choose , FloSeal place uterine cavity . The study participant know whether received FloSeal . A balloon pressure device place uterine cavity 20 individual leave place 5 minute . After allotted time , balloon device remove . The hysterectomy complete appropriately use standard method technique . The uterus , remove evaluate pathologically determine effect FloSeal upon tissue cavity treat compare analysis individual receive FloSeal . The pathologist know patient receive receive FloSeal . This use FloSeal currently FDA approve use compound . The goal study obtain FDA approval use situation .</brief_summary>
	<brief_title>Intrauterine Use FloSeal : Is Safe Useful ?</brief_title>
	<detailed_description>Patients follow fully recover surgery , usually 6 8 week . Any complication duly note treated appropriately . The final end point follow patient finally discharge care achieve usually perceived return normal activity .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<criteria>Women undergo hysterectomy nonmalignant indication Malignancy Inability remove uterus without morcellation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>type 0 myoma</keyword>
	<keyword>type 1 myoma</keyword>
	<keyword>type 2 myoma</keyword>
	<keyword>bleeding</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>hysteroscopy</keyword>
	<keyword>FloSeal</keyword>
</DOC>